Symvess acellular vessel introduced at live simulation event by Humacyte

Symvess acellular vessel introduced at live simulation event by Humacyte
Humacyte launches Symvess SIM lab

Humacyte is hosting a Hands-On Simulation Lab featuring its Symvess acellular tissue engineered vessel-type (ATEV) technology today and tomorrow.

The VAM TOUCHPOINT Hands-On / SIM Lab allows participants to directly practice using these innovative vessels in a controlled environment, reflecting the company’s drive to advance real-world clinical training. Details on the specific educational modules or participant outcomes have not yet been provided. Details are being clarified.

Humacyte recently received a contract from U.S. Veterans Affairs to expand access to its Symvess acellular tissue engineered vessel, according to a previous announcement. The company is also preparing to present interim results from a women-only vascular access study at a specialized forum on June 11, 2026, as reported earlier. These developments follow ongoing efforts by Humacyte to advance the clinical use and validation of its vascular implant technologies.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.
Weekly Top Bonuses
up to $2,500
deposit bonus for all clients
CLAIM BONUS
Your capital is at risk.